10/07/2026
A 22-mile move can have a global regulatory impact. When OriGen Biomedical moved manufacturing operations to our new Grand Avenue Parkway facility, the transition extended across 98 global markets, each with its own regulatory requirements and timelines. With support from MDSAP, ISO 13485, and RegDesk, our Regulatory Affairs team coordinated market-specific activities and documentation across our global network.
Read the full article by Carissa Bishop, Regulatory Affairs Project Manager, to learn how OriGen navigated this complex facility transition.
https://buff.ly/mfVHE4P